search
Back to results

Physical Exercise Augmented CBT for GAD (PEXACOG)

Primary Purpose

Generalized Anxiety Disorder

Status
Active
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Cognitive Behavioural Therapy
Physical Exercise
Placebo control
Sponsored by
Solli Distriktspsykiatriske Senter
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Generalized Anxiety Disorder focused on measuring GAD, CBT, Physical exercise, Older adults

Eligibility Criteria

60 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Primary diagnosis of GAD

Exclusion Criteria:

  • Substance abuse
  • Use of benzodiazepines, use of antipsychotica
  • Lack of ability to stabilize other psychotropic medication during participating in the study
  • Medical condition that precludes participation in physical exercise
  • Severe major depression as determined by the MINI International Neuropsychiatric Interview
  • Life-time history of psychosis and/or mania
  • Participation in other ongoing psychotherapy
  • Organic brain disease
  • Positive screening for dementia with Mini Mental State Examination
  • Currently engaged in a regular physical exercise program

Sites / Locations

  • Solli DPS

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

CBT augmented with physical exercise

CBT and placebo control

Arm Description

Patients receive 10 sessions of cognitive behavioural therapy for generalized anxiety disorder. Patients also receive 5 weeks of physical exercise pre-treatment, and 10 weeks of physical exercise alongside CBT. Both treatment and physical exercise is administered individually.

Patients receive 10 sessions of cognitive behavioural therapy for generalized anxiety disorder. Patients also receive 5 weeks of placebo control (15 minutes telephone follow-up call each week) pre-treatment, and 10 weeks of attention placebo alongside CBT. Both treatment and placebo control is administered individually.

Outcomes

Primary Outcome Measures

Changes in The Penn State Worry Questionnaire
Assesses symptom severity of GAD
Change in clinical diagnosis after treatment assessed by independent, blinded rater with Anxiety Disorders Interview Schedule (ADIS-IV)
Remission rates. Assessed by independent, blinded rater with Anxiety Disorders Interview Schedule (ADIS-IV)

Secondary Outcome Measures

Geriatric Anxiety Inventory
Generalized Anxiety Disorder 7-item scale (GAD-7)
Beck Anxiety Inventory
Beck Depression Inventory - II
Bergen Insomnia Scale
Quality of Life Inventory
International Physical Activity Questionnaire (IPAQ)
5-item Treatment Credibility and Expectancy Scale (CES)

Full Information

First Posted
February 5, 2016
Last Updated
November 23, 2022
Sponsor
Solli Distriktspsykiatriske Senter
Collaborators
University of Bergen, Norwegian University of Science and Technology, University of Oslo, University of California, Berkeley, William Paterson University of New Jersey, Ohio State University
search

1. Study Identification

Unique Protocol Identification Number
NCT02690441
Brief Title
Physical Exercise Augmented CBT for GAD
Acronym
PEXACOG
Official Title
Physical Exercise Augmented Cognitive Behaviour Therapy for Older Adults With Generalised Anxiety Disorder
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
March 2016 (Actual)
Primary Completion Date
November 2023 (Anticipated)
Study Completion Date
December 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Solli Distriktspsykiatriske Senter
Collaborators
University of Bergen, Norwegian University of Science and Technology, University of Oslo, University of California, Berkeley, William Paterson University of New Jersey, Ohio State University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Generalised anxiety disorder (GAD) is a severe and debilitating anxiety disorder that is highly prevalent among older adults. Anxiety and GAD is a well-documented risk factor for the development of other severe conditions such as depression and dementia, and effective treatments are called for. However, recommended treatment for GAD has consistently been found to yield blunted response rates for older adults compared to younger patients. The purpose of this study is to evaluate the effects of exercise-augmented cognitive behaviour therapy for older adults with GAD. Exercise augmented CBT is expected to yield better results than standard CBT in terms of greater reduction of symptoms and increased rates of remission. The investigators will also investigate the effects of treatment on biological, physiological and neuropsychological measures.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Generalized Anxiety Disorder
Keywords
GAD, CBT, Physical exercise, Older adults

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
53 (Actual)

8. Arms, Groups, and Interventions

Arm Title
CBT augmented with physical exercise
Arm Type
Experimental
Arm Description
Patients receive 10 sessions of cognitive behavioural therapy for generalized anxiety disorder. Patients also receive 5 weeks of physical exercise pre-treatment, and 10 weeks of physical exercise alongside CBT. Both treatment and physical exercise is administered individually.
Arm Title
CBT and placebo control
Arm Type
Active Comparator
Arm Description
Patients receive 10 sessions of cognitive behavioural therapy for generalized anxiety disorder. Patients also receive 5 weeks of placebo control (15 minutes telephone follow-up call each week) pre-treatment, and 10 weeks of attention placebo alongside CBT. Both treatment and placebo control is administered individually.
Intervention Type
Behavioral
Intervention Name(s)
Cognitive Behavioural Therapy
Intervention Description
Cognitive behavioural therapy conducted individually. 10 weekly sessions, first session lasts 90 minutes, the remaining sessions last 45 minutes.
Intervention Type
Behavioral
Intervention Name(s)
Physical Exercise
Intervention Description
Manualised exercise. 15 weekly sessions with instructor, and two weekly unsupervised sessions performed individually.
Intervention Type
Behavioral
Intervention Name(s)
Placebo control
Other Intervention Name(s)
Telephone follow-up
Intervention Description
One follow-up telephone call à 15 minutes each week for 15 weeks. Aims to control for therapist contact in physical exercise condition and total duration of treatment.
Primary Outcome Measure Information:
Title
Changes in The Penn State Worry Questionnaire
Description
Assesses symptom severity of GAD
Time Frame
Baseline, after pre-treatment (up to 8 weeks after baseline), post-treatment (up to 20 weeks after baseline), 6 months follow-up and 12 months follow-up
Title
Change in clinical diagnosis after treatment assessed by independent, blinded rater with Anxiety Disorders Interview Schedule (ADIS-IV)
Description
Remission rates. Assessed by independent, blinded rater with Anxiety Disorders Interview Schedule (ADIS-IV)
Time Frame
Baseline and post-treatment (up to 20 weeks after baseline)
Secondary Outcome Measure Information:
Title
Geriatric Anxiety Inventory
Time Frame
Baseline, after pre-treatment (up to 8 weeks after baseline), post-treatment (up to 20 weeks after baseline), 6 months follow-up and 12 months follow-up
Title
Generalized Anxiety Disorder 7-item scale (GAD-7)
Time Frame
Baseline, after pre-treatment (up to 8 weeks after baseline), post-treatment (up to 20 weeks after baseline), 6 months follow-up and 12 months follow-up
Title
Beck Anxiety Inventory
Time Frame
Baseline, after pre-treatment (up to 8 weeks after baseline), post-treatment (up to 20 weeks after baseline), 6 months follow-up and 12 months follow-up
Title
Beck Depression Inventory - II
Time Frame
Baseline, after pre-treatment (up to 8 weeks after baseline), post-treatment (up to 20 weeks after baseline), 6 months follow-up and 12 months follow-up
Title
Bergen Insomnia Scale
Time Frame
Baseline, after pre-treatment (up to 8 weeks after baseline), post-treatment (up to 20 weeks after baseline), 6 months follow-up and 12 months follow-up
Title
Quality of Life Inventory
Time Frame
Baseline, after pre-treatment (up to 8 weeks after baseline), post-treatment (up to 20 weeks after baseline), 6 months follow-up and 12 months follow-up
Title
International Physical Activity Questionnaire (IPAQ)
Time Frame
Baseline, after pre-treatment (up to 8 weeks after baseline), post-treatment (up to 20 weeks after baseline), 6 months follow-up and 12 months follow-up
Title
5-item Treatment Credibility and Expectancy Scale (CES)
Time Frame
Baseline
Other Pre-specified Outcome Measures:
Title
Function and structure of prefrontal lobes and limbic system
Description
Functional Magnetic Resonance Imaging (fMRI) conducted with a 3-Tesla scanner.
Time Frame
Baseline, post-treatment (up to 20 weeks after baseline) and 12 months follow-up
Title
Blood samples
Description
Serum concentrations of mature and pro brain-derived neurotropic factor
Time Frame
Baseline, after pre-treatment (up to 8 weeks after baseline), post-treatment (up to 20 weeks after baseline), 6 months follow-up and 12 months follow-up
Title
Saliva samples
Description
To measure cortisol
Time Frame
Baseline, after pre-treatment (up to 8 weeks after baseline), post-treatment (up to 20 weeks after baseline), 6 months follow-up and 12 months follow-up
Title
Three subtests from Delis-Kaplan Executive Function System battery (D-KEFS; Delis, Kaplan & Kramer, 2001)
Description
Measures executive function
Time Frame
Baseline, post-treatment (up to 20 weeks after baseline) and 12 months follow-up
Title
Wisconsin Card Sorting Test: Computer Version 4 research edition (WCST-CV4; Heaton, PAR staff & Goldin 2003).
Description
Measures executive function
Time Frame
Baseline, post-treatment (up to 20 weeks after baseline) and 12 months follow-up
Title
The California Verbal Learning Test (CVLT; Delis, Kramer & Kaplan, 1994).
Description
Measures memory
Time Frame
Baseline, post-treatment (up to 20 weeks after baseline) and 12 months follow-up
Title
Wechsler Abbreviated Scale of Intelligence
Description
Two subtests from Wechsler Abbreviated Scale of Intelligence (WASI; Wechsler, 1999) will be administered to assess IQ level.
Time Frame
Baseline
Title
Ambulatory Electrocardiogram (ECG)
Description
Measures heart rate variability (HRV)
Time Frame
Baseline, after pre-treatment (up to 8 weeks after baseline), post-treatment (up to 20 weeks after baseline), 6 months follow-up and 12 months follow-up
Title
Ekblom-Bak submaximal ergometer cycle test
Description
Test for prediction of VO2 max, which gives an indication of physical fitness
Time Frame
Baseline, after pre-treatment (up to 8 weeks after baseline), post-treatment (up to 20 weeks after baseline), 6 months follow-up and 12 months follow-up
Title
Strength test battery
Description
Measures submaximal physical strength, which gives an indication of physical fitness.
Time Frame
Baseline, after pre-treatment (up to 8 weeks after baseline), post-treatment (up to 20 weeks after baseline), 6 months follow-up and 12 months follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Primary diagnosis of GAD Exclusion Criteria: Substance abuse Use of benzodiazepines, use of antipsychotica Lack of ability to stabilize other psychotropic medication during participating in the study Medical condition that precludes participation in physical exercise Severe major depression as determined by the MINI International Neuropsychiatric Interview Life-time history of psychosis and/or mania Participation in other ongoing psychotherapy Organic brain disease Positive screening for dementia with Mini Mental State Examination Currently engaged in a regular physical exercise program
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anders Hovland, PhD
Organizational Affiliation
Solli DPS, University of Bergen
Official's Role
Principal Investigator
Facility Information:
Facility Name
Solli DPS
City
Bergen
State/Province
Nesttun
ZIP/Postal Code
5228
Country
Norway

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30885256
Citation
Stavestrand SH, Sirevag K, Nordhus IH, Sjobo T, Endal TB, Nordahl HM, Specht K, Hammar A, Halmoy A, Martinsen EW, Andersson E, Hjelmervik H, Mohlman J, Thayer JF, Hovland A. Physical exercise augmented cognitive behaviour therapy for older adults with generalised anxiety disorder (PEXACOG): study protocol for a randomized controlled trial. Trials. 2019 Mar 18;20(1):174. doi: 10.1186/s13063-019-3268-9. Erratum In: Trials. 2020 Apr 6;21(1):317.
Results Reference
derived

Learn more about this trial

Physical Exercise Augmented CBT for GAD

We'll reach out to this number within 24 hrs